Literature DB >> 28469800

Erythema elevatum diutinum involving palms and soles: a case report and literature review.

Uma Keyal1, Anil Kumar Bhatta1, Yeqiang Liu1.   

Abstract

Erythema elevatum diutinum (EED) is a rare chronic inflammatory dermatosis and a part of the spectrum of cutaneous leukocytoclasticvasculitis. The most common site of involvement is extensor surface of the extremities, with a predilection for the skin overlying joints, particularly hands, feet, elbows and knees, as well as buttocks and Achilles tendons. Here we report a case of EED with atypical presentation involving palms and soles. The patient showed dramatic response to the treatment with prednisolone combined with Tripterygium wilfordii glycoside (TWP). The lesions improved significantly after three months of therapy. We will also review the atypical cases of EED that were previously published in English literature.

Entities:  

Keywords:  Erythema elevatum diutinum; leukocytoclasticvasculitis; multiple myeloma

Year:  2017        PMID: 28469800      PMCID: PMC5411943     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  12 in total

Review 1.  Erythema elevatum diutinum.

Authors:  L E Gibson; R A el-Azhary
Journal:  Clin Dermatol       Date:  2000 May-Jun       Impact factor: 3.541

2.  Erythema elevatum diutinum: a clinicopathological study.

Authors:  S M Wilkinson; J S English; N P Smith; E Wilson-Jones; R K Winkelmann
Journal:  Clin Exp Dermatol       Date:  1992-03       Impact factor: 3.470

3.  Erythema elevatum diutinum with oral ulceration.

Authors:  T Maruthappu; S Tharakaram; E Calonje; P J Shirlaw; J Setterfield
Journal:  Br J Dermatol       Date:  2012-05-08       Impact factor: 9.302

4.  Erythema elevatum diutinum and hypothyroidism: coincidence or causal relationship?

Authors:  Denise Camargo Cirvidiu; Beatriz Lopes Ferraz Elias; Juliana Chaib Ferraira Jorge; Márcia Lanzoni de Alvarenga Lira; Samuel Henrique Mandelbaum
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

5.  An atypical presentation of erythema elevatum diutinum involving palms and soles.

Authors:  Mohamadreza Barzegar; Cheyda Chams Davatchi; Maryam Akhyani; Azita Nikoo; Maryam Daneshpazhooh; Khalil Farsinejad
Journal:  Int J Dermatol       Date:  2009-01       Impact factor: 2.736

6.  An atypical distribution of erythema elevatum diutinum.

Authors:  G T Ben-Zvi; V Bardsley; N P Burrows
Journal:  Clin Exp Dermatol       Date:  2014-01-31       Impact factor: 3.470

Review 7.  Erythema elevatum diutinum in human immunodeficiency virus-infected patients--report of a case and review of the literature.

Authors:  F Dronda; A González-López; M Lecona; C Barros
Journal:  Clin Exp Dermatol       Date:  1996-05       Impact factor: 3.470

8.  Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.

Authors:  Jianan Ren; Xiuwen Wu; Nansheng Liao; Gefei Wang; Chaogang Fan; Song Liu; Huajian Ren; Yunzhao Zhao; Jieshou Li
Journal:  J Int Med Res       Date:  2013-01-24       Impact factor: 1.671

9.  Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis.

Authors:  Liang Ma; Bin Liu; Zhenyu Jiang; Yanfang Jiang
Journal:  Clin Rheumatol       Date:  2013-08-15       Impact factor: 2.980

10.  Effect of Tripterygium Wilfordii Polyglycoside on Experimental Prostatitis Caused by Ureaplasma Urealyticum in Rats.

Authors:  Pingnan Shan; Zhiyong Lu; Lihong Ye; Yaqin Fang; Suhong Tan; Guohong Xuan; Jincheng Ru; Liming Mao
Journal:  Med Sci Monit       Date:  2016-10-15
View more
  2 in total

1.  Rare presentation of erythema elevatum diutinum.

Authors:  Charlotte Paugam; Othman Laghmari; Jean-Jacques Renaut; Sébastien Barbarot
Journal:  JAAD Case Rep       Date:  2018-09-18

Review 2.  Cutaneous manifestations of monoclonal gammopathy.

Authors:  Jean-Sebastien Claveau; David A Wetter; Shaji Kumar
Journal:  Blood Cancer J       Date:  2022-04-11       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.